EPS for Qiagen NV (QGEN) Expected At $0.32

October 13, 2017 - By Winifred Garcia

 EPS for Qiagen NV (QGEN) Expected At $0.32

Analysts await Qiagen NV (NASDAQ:QGEN) to report earnings on November, 1. They expect $0.32 EPS, up 6.67 % or $0.02 from last year’s $0.3 per share. QGEN’s profit will be $73.80M for 27.10 P/E if the $0.32 EPS becomes a reality. After $0.30 actual EPS reported by Qiagen NV for the previous quarter, Wall Street now forecasts 6.67 % EPS growth. About 1.85 million shares traded or 20.13% up from the average. Qiagen NV (NASDAQ:QGEN) has risen 54.62% since October 13, 2016 and is uptrending. It has outperformed by 37.92% the S&P500.

Qiagen NV (NASDAQ:QGEN) Ratings Coverage

Among 13 analysts covering Qiagen (NASDAQ:QGEN), 4 have Buy rating, 0 Sell and 9 Hold. Therefore 31% are positive. Qiagen had 21 analyst reports since August 3, 2015 according to SRatingsIntel. Independent Research upgraded the shares of QGEN in report on Tuesday, August 1 to “Hold” rating. Piper Jaffray maintained it with “Hold” rating and $2900 target in Friday, July 28 report. On Thursday, July 30 the stock rating was maintained by Mizuho with “Neutral”. The firm has “Neutral” rating by Citigroup given on Tuesday, March 15. The firm earned “Hold” rating on Wednesday, September 27 by Cowen & Co. As per Thursday, July 30, the company rating was maintained by Barclays Capital. Jefferies maintained Qiagen NV (NASDAQ:QGEN) on Monday, June 5 with “Hold” rating. The firm earned “Hold” rating on Wednesday, September 13 by Jefferies. The stock has “Hold” rating by Stifel Nicolaus on Thursday, November 12. The company was maintained on Monday, August 14 by Cowen & Co.

QIAGEN N.V. is a holding company. The company has market cap of $8.00 billion. The Firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. It has a 105.62 P/E ratio. The Company’s Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems.

Another recent and important Qiagen NV (NASDAQ:QGEN) news was published by Investorplace.com which published an article titled: “Qiagen NV (QGEN) Hold Recommendation Confirmed” on October 05, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.